Abstract
Human albumin has been used extensively for decades as a nonwhole blood plasma replacement fluid in the perioperative and critical care setting. Its potential advantages as a highly effective volume expander must be weighed, however, against its potential harm for patients in the context of various neurological states and for various neurosurgical interventions. This narrative review explores the physiological considerations of intravenous human albumin as a replacement fluid and examines the extant clinical evidence for and against its use within the various facets of modern neuroanesthesia and neurocritical care practice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 293-299 |
| Number of pages | 7 |
| Journal | Journal of Neurosurgical Anesthesiology |
| Volume | 33 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1 2021 |
Funding
Supported by Northwestern University Department of Anesthesiology.
Keywords
- human serum albumin
- intravenous infusion
- neuroanesthesia
- neurosurgery
- neurosurgical anesthesia
- perioperative care
ASJC Scopus subject areas
- Surgery
- Clinical Neurology
- Anesthesiology and Pain Medicine